BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 30791849)

  • 1. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery.
    Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of SBA-15 for furosemide oral delivery enhancement.
    Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
    Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen.
    Xin W; Wang Y; Guo X; Gou K; Li J; Li S; Zhao L; Li H
    Int J Nanomedicine; 2020; 15():7451-7468. PubMed ID: 33116481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods.
    Dadej A; Woźniak-Braszak A; Bilski P; Piotrowska-Kempisty H; Józkowiak M; Pawełczyk A; Dadej D; Łażewska D; Jelińska A
    Eur J Pharm Sci; 2022 Apr; 171():106133. PubMed ID: 35066153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mesoporous carbon aerogels as carriers of the non-steroidal anti-inflammatory drug ibuprofen.
    Eleftheriadis GK; Filippousi M; Tsachouridou V; Darda MA; Sygellou L; Kontopoulou I; Bouropoulos N; Steriotis T; Charalambopoulou G; Vizirianakis IS; Van Tendeloo G; Fatouros DG
    Int J Pharm; 2016 Dec; 515(1-2):262-270. PubMed ID: 27717918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
    Rehman F; Rahim A; Airoldi C; Volpe PLO
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
    Dening TJ; Taylor LS
    Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
    Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
    Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
    Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
    Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The applicability of ordered mesoporous SBA-15 and its hydrophobic glutaraldehyde-bridge derivative to improve ibuprofen-loading in releasing system.
    Rehman F; Volpe PL; Airoldi C
    Colloids Surf B Biointerfaces; 2014 Jul; 119():82-9. PubMed ID: 24819430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs.
    Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.
    Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ
    Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.